MediCrops acquires Swiss Alpinopharma.
A strategic move to enhance digital patient care in the booming European cannabis market.(Pfäffikon, Schwyz/Berlin) – International Swiss-based health tech company MediCrops Holding AG (‘MediCrops’) has acquired Berlin-based company Swiss Alpinopharma GmbH (‘Swiss Alpinopharma’), a disruptive market leader in the field of medical cannabis and owner of telemedicine platform Enmedify . Swiss Alpinopharma also offers doctors-certified CME training on the use of medical cannabis. The acquisition consolidates MediCrops’ position in a European market that is expected to